Drugs / Calcipotriol BDP gel
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT02132936 Comparator | Jun 2014 → Feb 2015 | psoriasis | LEO Pharma | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Calcipotriol BDP gel | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02132936 ↗ |
| Route | Topical | “Calcipotriol BDP gel, containing calcipotriol (as hydrate) 50 mcg/g and betamethasone 0.5 mg/g (as dipropionate), 60 g per bottle, applied once daily up to 12 weeks” NCT02132936 ↗ |